Generated by AI
QuidelOrtho Corporation is a diagnostic healthcare company that develops, manufactures, and markets testing solutions used across the healthcare continuum. The company focuses on in vitro diagnostics, with products and platforms spanning immunoassay, molecular testing, clinical chemistry, point-of-care testing, labs, and transfusion medicine. Its offerings are designed to support disease detection, monitoring, and clinical decision-making in settings ranging from hospitals and reference laboratories to blood banks and other care environments. QuidelOrtho serves a global market and plays an important role in providing tools that help clinicians identify infections, manage chronic conditions, and support transfusion safety. Headquartered in San Diego, California, QuidelOrtho Corporation combines broad diagnostic expertise with a diversified portfolio that addresses both routine and specialized testing needs in modern healthcare.
Website9975 Summers Ridge Road
San Diego, CA, 92121
United States
The latest articles about QDEL.
QuidelOrtho Corp (QDEL) narrows full-year guidance as China revenue plunges 45%, while a new $80 million cost transformation program and breakeven free cash flow signal progress on deleveraging.
QuidelOrtho (NASDAQ:QDEL) reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results. The company said revenue rose 3% excluding China, respiratory testing and the
Summary of Aug 7's posts. Generated by AI.
Summary of Feb 14's posts. Generated by AI.
Summary of Jul 18's posts. Generated by AI.
Summary of Jun 29's posts. Generated by AI.
Investors talking about QDEL also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.